EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

The evolution of antimicrobial peptide resistance in Pseudomonas aeruginosa is severely constrained by random peptide mixtures

Bernardo Antunes iD, Caroline Zanchi iD, Paul R Johnston, Bar Maron, Christopher Witzany, Roland R Regoes, Zvi Hayouka, Jens Rolff iD

PLOS Biology · 02.07.2024 · 22 (7) · e3002692

DOI: 10.1371/journal.pbio.3002692 ↗

Kurz gefasst

Fachartikel in der Zeitschrift PLOS Biology, online erschienen am 02.07.2024. Verfasst von Bernardo Antunes und 7 weiteren Autor:innen. Beteiligte Einrichtung: Freie Universität Berlin, Evolutionary Biology, Berlin, Germany. Hauptthemen laut MEDLINE: Pseudomonas aeruginosa, Anti-Bacterial Agents, Antimicrobial Peptides, Microbial Sensitivity Tests. Die Arbeit wurde bisher 18-mal zitiert (Crossref) und nennt 128 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Freie Universität Berlin (FUB), Hebrew University of Jerusalem (HUJI), Volkswagen Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The prevalence of antibiotic-resistant pathogens has become a major threat to public health, requiring swift initiatives for discovering new strategies to control bacterial infections. Hence, antibiotic stewardship and rapid diagnostics, but also the development, and prudent use, of novel effective antimicrobial agents are paramount. Ideally, these agents should be less likely to select for resistance in pathogens than currently available conventional antimicrobials. The usage of antimicrobial peptides (AMPs), key components of the innate immune response, and combination therapies, have been proposed as strategies to diminish the emergence of resistance. Herein, we investigated whether newly developed random antimicrobial peptide mixtures (RPMs) can significantly reduce the risk of resistance evolution in vitro to that of single sequence AMPs, using the ESKAPE pathogen Pseudomonas aeruginosa ( P . aeruginosa ) as a model gram-negative bacterium. Infections of this pathogen are difficult to treat due the inherent resistance to many drug classes, enhanced by the capacity to form biofilms. P . aeruginosa was experimentally evolved in the presence of AMPs or RPMs, subsequentially assessing the extent of resistance evolution and cross-resistance/collateral sensitivity between treatments. Furthermore, the fitness costs of resistance on bacterial growth were studied and whole-genome sequencing used to investigate which mutations could be candidates for causing resistant phenotypes. Lastly, changes in the pharmacodynamics of the evolved bacterial strains were examined. Our findings suggest that using RPMs bears a much lower risk of resistance evolution compared to AMPs and mostly prevents cross-resistance development to other treatments, while maintaining (or even improving) drug sensitivity. This strengthens the case for using random cocktails of AMPs in favour of single AMPs, against which resistance evolved in vitro, providing an alternative to classic antibiotics worth pursuing.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Pseudomonas aeruginosaAnti-Bacterial AgentsAntimicrobial PeptidesMicrobial Sensitivity TestsDrug Resistance, BacterialBiofilmsPseudomonas Infections

Substanzen

Anti-Bacterial AgentsAntimicrobial Peptides

Autor:innen und Institutionen

  • Freie Universität Berlin, Evolutionary Biology, Berlin, Germany.
  • Institute of Biochemistry, Food Science and Nutrition, The Hebrew University of Jerusalem, Rehovot, Israel.
  • Berlin Centre for Genomics in Biodiversity Research, Berlin, Germany.
  • University of St. Andrews, School of Medicine, North Haugh, St Andrews, Fife, United Kingdom.
  • Institute of Integrative Biology, ETH Zurich, Zurich, Switzerland.

ORCID-Profile: Bernardo Antunes, Caroline Zanchi, Jens Rolff

Förderung

  • Freie Universität Berlin (FUB)
  • Hebrew University of Jerusalem (HUJI)
  • Volkswagen Foundation
  • DFG
  • Deutsche Forschungsgemeinschaft

Zitieren

APA

Antunes, B., Zanchi, C., Johnston, P. R., Maron, B., Witzany, C., Regoes, R. R., Hayouka, Z., & Rolff, J. (2024). The evolution of antimicrobial peptide resistance in Pseudomonas aeruginosa is severely constrained by random peptide mixtures. PLOS Biology, 22(7), e3002692. https://doi.org/10.1371/journal.pbio.3002692

Vancouver

Antunes B, Zanchi C, Johnston PR, Maron B, Witzany C, Regoes RR, et al. The evolution of antimicrobial peptide resistance in Pseudomonas aeruginosa is severely constrained by random peptide mixtures. PLOS Biology. 2024;22(7):e3002692. doi:10.1371/journal.pbio.3002692

BibTeX
@article{Antunes2024,
  author = {Antunes, Bernardo and Zanchi, Caroline and Johnston, Paul R and Maron, Bar and Witzany, Christopher and Regoes, Roland R and Hayouka, Zvi and Rolff, Jens},
  title = {The evolution of antimicrobial peptide resistance in Pseudomonas aeruginosa is severely constrained by random peptide mixtures},
  journal = {PLOS Biology},
  year = {2024},
  volume = {22},
  number = {7},
  pages = {e3002692},
  doi = {10.1371/journal.pbio.3002692}
}
Kostenlos starten →